Question 1

What specific blood tests will be performed during this study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Hypercoagulable Parameters as Predictors of Thrombotic Events and Prognosis in Patients With Advanced Non-Small Cell Lung Carcinoma clinical trial (NCT00192829). Contact the study team or your healthcare provider for specific answers.

Question 2

How might the results of this study impact my treatment options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Hypercoagulable Parameters as Predictors of Thrombotic Events and Prognosis in Patients With Advanced Non-Small Cell Lung Carcinoma clinical trial (NCT00192829). Contact the study team or your healthcare provider for specific answers.

Question 3

Are there any risks associated with participating in this study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Hypercoagulable Parameters as Predictors of Thrombotic Events and Prognosis in Patients With Advanced Non-Small Cell Lung Carcinoma clinical trial (NCT00192829). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to come in for blood tests?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Hypercoagulable Parameters as Predictors of Thrombotic Events and Prognosis in Patients With Advanced Non-Small Cell Lung Carcinoma clinical trial (NCT00192829). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects from the blood tests?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Hypercoagulable Parameters as Predictors of Thrombotic Events and Prognosis in Patients With Advanced Non-Small Cell Lung Carcinoma clinical trial (NCT00192829). Contact the study team or your healthcare provider for specific answers.

Question 6

Is there any compensation or support for travel if I participate?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Hypercoagulable Parameters as Predictors of Thrombotic Events and Prognosis in Patients With Advanced Non-Small Cell Lung Carcinoma clinical trial (NCT00192829). Contact the study team or your healthcare provider for specific answers.

What this study is about